H-Wave<sup>®</sup> Device Stimulation: A Critical Review
Pain treatments have historically centered on drugs, but an “opioid crisis” has necessitated new standards of care, with a paradigm shift towards multi-modal pain management emphasizing early movement, non-narcotics, and various adjunctive therapies. Electrotherapies remain understudied and most lac...
Guardado en:
Autores principales: | , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b5d629c6fa6f40eb8a275c2e56329699 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:b5d629c6fa6f40eb8a275c2e56329699 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:b5d629c6fa6f40eb8a275c2e563296992021-11-25T18:07:27ZH-Wave<sup>®</sup> Device Stimulation: A Critical Review10.3390/jpm111111342075-4426https://doaj.org/article/b5d629c6fa6f40eb8a275c2e563296992021-11-01T00:00:00Zhttps://www.mdpi.com/2075-4426/11/11/1134https://doaj.org/toc/2075-4426Pain treatments have historically centered on drugs, but an “opioid crisis” has necessitated new standards of care, with a paradigm shift towards multi-modal pain management emphasizing early movement, non-narcotics, and various adjunctive therapies. Electrotherapies remain understudied and most lack high-quality clinical trials, despite a desperate need for effective adjunctive options. A systematic search of human clinical studies on H-Wave<sup>®</sup> device stimulation (HWDS) was conducted as well as a comprehensive review of articles articulating possible HWDS mechanisms of action. Studies unrelated to H-Wave were excluded. Data synthesis summarizes outcomes and study designs, categorized as pre-clinical or clinical. Pre-clinical studies demonstrated that HWDS utilizes a biphasic waveform to induce non-fatiguing muscle contractions which positively affect nerve function, blood and lymph flow. Multiple clinical studies have reported significant benefits for diabetic and non-specific neuropathic pain, where function also improved, and pain medication usage substantially dropped. In conclusion, low- to moderate-quality HWDS studies have reported reduced pain, restored functionality, and lower medication use in a variety of disorders, although higher-quality research is needed to verify condition-specific applicability. HWDS has enough reasonable evidence to be considered as an adjunctive component of non-opioid multi-modal pain management, given its excellent safety profile and relative low cost. Level of Evidence: III.Tyler K. WilliamsonHugo C. RodriguezAndrew GonzabaNeil PoddarStephen M. NorwoodAshim GuptaMDPI AGarticlepainanalgesianeurogenicelectrotherapyneuromuscular stimulationH-WaveMedicineRENJournal of Personalized Medicine, Vol 11, Iss 1134, p 1134 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
pain analgesia neurogenic electrotherapy neuromuscular stimulation H-Wave Medicine R |
spellingShingle |
pain analgesia neurogenic electrotherapy neuromuscular stimulation H-Wave Medicine R Tyler K. Williamson Hugo C. Rodriguez Andrew Gonzaba Neil Poddar Stephen M. Norwood Ashim Gupta H-Wave<sup>®</sup> Device Stimulation: A Critical Review |
description |
Pain treatments have historically centered on drugs, but an “opioid crisis” has necessitated new standards of care, with a paradigm shift towards multi-modal pain management emphasizing early movement, non-narcotics, and various adjunctive therapies. Electrotherapies remain understudied and most lack high-quality clinical trials, despite a desperate need for effective adjunctive options. A systematic search of human clinical studies on H-Wave<sup>®</sup> device stimulation (HWDS) was conducted as well as a comprehensive review of articles articulating possible HWDS mechanisms of action. Studies unrelated to H-Wave were excluded. Data synthesis summarizes outcomes and study designs, categorized as pre-clinical or clinical. Pre-clinical studies demonstrated that HWDS utilizes a biphasic waveform to induce non-fatiguing muscle contractions which positively affect nerve function, blood and lymph flow. Multiple clinical studies have reported significant benefits for diabetic and non-specific neuropathic pain, where function also improved, and pain medication usage substantially dropped. In conclusion, low- to moderate-quality HWDS studies have reported reduced pain, restored functionality, and lower medication use in a variety of disorders, although higher-quality research is needed to verify condition-specific applicability. HWDS has enough reasonable evidence to be considered as an adjunctive component of non-opioid multi-modal pain management, given its excellent safety profile and relative low cost. Level of Evidence: III. |
format |
article |
author |
Tyler K. Williamson Hugo C. Rodriguez Andrew Gonzaba Neil Poddar Stephen M. Norwood Ashim Gupta |
author_facet |
Tyler K. Williamson Hugo C. Rodriguez Andrew Gonzaba Neil Poddar Stephen M. Norwood Ashim Gupta |
author_sort |
Tyler K. Williamson |
title |
H-Wave<sup>®</sup> Device Stimulation: A Critical Review |
title_short |
H-Wave<sup>®</sup> Device Stimulation: A Critical Review |
title_full |
H-Wave<sup>®</sup> Device Stimulation: A Critical Review |
title_fullStr |
H-Wave<sup>®</sup> Device Stimulation: A Critical Review |
title_full_unstemmed |
H-Wave<sup>®</sup> Device Stimulation: A Critical Review |
title_sort |
h-wave<sup>®</sup> device stimulation: a critical review |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/b5d629c6fa6f40eb8a275c2e56329699 |
work_keys_str_mv |
AT tylerkwilliamson hwavesupsupdevicestimulationacriticalreview AT hugocrodriguez hwavesupsupdevicestimulationacriticalreview AT andrewgonzaba hwavesupsupdevicestimulationacriticalreview AT neilpoddar hwavesupsupdevicestimulationacriticalreview AT stephenmnorwood hwavesupsupdevicestimulationacriticalreview AT ashimgupta hwavesupsupdevicestimulationacriticalreview |
_version_ |
1718411637915910144 |